| Chapter title |
New Approaches in Immunotherapy for the Treatment of Lung Cancer.
|
|---|---|
| Chapter number | 428 |
| Book title |
Cancer Vaccines
|
| Published in |
Current topics in microbiology and immunology, December 2014
|
| DOI | 10.1007/82_2014_428 |
| Pubmed ID | |
| Book ISBNs |
978-3-31-923909-5, 978-3-31-923910-1
|
| Authors |
Sonia Quaratino, Ulf Forssmann, Jens-Peter Marschner |
| Abstract |
Despite the several advances in the last few years into treatment of advanced lung cancer, the 5-year survival remains extremely low. New therapeutic strategies are currently under investigation, and immunotherapyImmunotherapy seems to offer a promising treatment alternative. In the last decade, therapeutic cancer vaccinesVaccines in lung cancer have been rather disappointing, mainly due to the lack of efficient predictive biomarkers. A better refinement of the patient population that might respond to treatment might finally lead to a success story. For the first time, the immune checkpointCheckpoint inhibitorsInhibitors are demonstrating sustained antitumor response and improved survival and they may be the first immunotherapeutics available for patients with lung cancer. |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 30 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 5 | 17% |
| Student > Master | 4 | 13% |
| Student > Doctoral Student | 3 | 10% |
| Researcher | 3 | 10% |
| Student > Ph. D. Student | 3 | 10% |
| Other | 6 | 20% |
| Unknown | 6 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 12 | 40% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 13% |
| Biochemistry, Genetics and Molecular Biology | 3 | 10% |
| Chemical Engineering | 1 | 3% |
| Nursing and Health Professions | 1 | 3% |
| Other | 3 | 10% |
| Unknown | 6 | 20% |